Datasets:

HHS-Official
/

nchs-vsrr-quarterly-provisional-estimates-for-sele

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 924 rows

Year and Quarter stringclasses 11 values	Time Period stringclasses 2 values	Cause of Death stringclasses 21 values	Rate Type stringclasses 2 values	Unit stringclasses 1 value	Overall Rate float64 1.1 1.12k ⌀	Rate Sex Female float64 0.5 1.04k ⌀	Rate Sex Male float64 1.8 1.19k ⌀	Rate Age 1-4 float64 0.1 29.5 ⌀	Rate Age 5-14 float64 0.1 16.2 ⌀	Rate Age 15-24 float64 0 88.4 ⌀	Rate Age 25-34 float64 0.2 182 ⌀	Rate Age 35-44 float64 0.1 290 ⌀	Rate Age 45-54 float64 0.1 530 ⌀	Rate Age 55-64 float64 1.8 1.15k ⌀	Rate 65-74 float64 2.3 2.3k ⌀	Rate Age 75-84 float64 1.3 5.48k ⌀	Rate Age 85 plus float64 0.6 16.3k ⌀	Rate Alaska float64 2.7 945 ⌀	Rate Alabama float64 0.9 1.42k ⌀	Rate Arkansas float64 0.7 1.41k ⌀	Rate Arizona float64 0.6 1.16k ⌀	Rate California float64 1.1 906 ⌀	Rate Colorado float64 0.4 882 ⌀	Rate Connecticut float64 0.5 1.07k ⌀	Rate District of Columbia float64 3.6 908 ⌀	Rate Delaware float64 1.6 1.28k ⌀	Rate Florida float64 1.6 1.2k ⌀	Rate Georgia float64 1.5 1.07k ⌀	Rate Hawaii float64 1.7 963 ⌀	Rate Iowa float64 0.5 1.18k ⌀	Rate Idaho float64 1.2 986 ⌀	Rate Illinois float64 0.6 1.11k ⌀	Rate Indiana float64 0.5 1.25k ⌀	Rate Kansas float64 0.5 1.27k ⌀	Rate Kentucky float64 0.7 1.45k ⌀	Rate Louisiana float64 1.4 1.29k ⌀	Rate Massachusetts float64 0.2 1k ⌀	Rate Maryland float64 1.8 1.04k ⌀	Rate Maine float64 0.9 1.34k ⌀	Rate Michigan float64 0.5 1.23k ⌀	Rate Minnesota float64 0.2 970 ⌀	Rate Missouri float64 0.4 1.33k ⌀	Rate Mississippi float64 1.5 1.49k ⌀	Rate Montana float64 2.5 1.18k ⌀	Rate North Carolina float64 1.1 1.2k ⌀	Rate North Dakota float64 2.3 984 ⌀	Rate Nebraska float64 0.8 1.06k ⌀	Rate New Hampshire float64 1.4 1.12k ⌀	Rate New Jersey float64 0.9 1.02k ⌀	Rate New Mexico float64 0.8 1.3k ⌀	Rate Nevada float64 0.9 1.14k ⌀	Rate New York float64 1.3 992 ⌀	Rate Ohio float64 0.7 1.37k ⌀	Rate Oklahoma float64 1.1 1.43k ⌀	Rate Oregon float64 0.5 1.12k ⌀	Rate Pennsylvania float64 0.5 1.3k ⌀	Rate Rhode Island float64 1.3 1.1k ⌀	Rate South Carolina float64 1.1 1.32k ⌀	Rate South Dakota float64 2.6 1.12k ⌀	Rate Tennessee float64 1.1 1.4k ⌀	Rate Texas float64 1.3 962 ⌀	Rate Utah float64 0.6 836 ⌀	Rate Virginia float64 0.8 1.08k ⌀	Rate Vermont float64 2 1.14k ⌀	Rate Washington float64 0.4 947 ⌀	Rate Wisconsin float64 0.4 1.15k ⌀	Rate West Virginia float64 0.8 1.78k ⌀	Rate Wyoming float64 2.4 1.16k ⌀
2023 Q1	3-month period	HIV disease	Age-adjusted	Deaths per 100,000	1.4	0.7	2.1	null	null	null	null	null	null	null	null	null	null	null	2.6	0.8	1.3	1.4	0.5	0.7	10.1	null	2.2	2.5	null	null	null	0.8	0.9	0.7	1.1	3.3	0.7	2.3	null	1.5	0.4	0.8	2.7	null	1.9	null	0.8	null	1.2	1.2	1.5	1.8	1.1	1.5	0.6	0.9	null	1.7	null	1.5	2	0.6	1.1	null	0.6	null	null	null
2023 Q1	3-month period	Homicide	Age-adjusted	Deaths per 100,000	6.9	2.8	10.9	null	null	null	null	null	null	null	null	null	null	7.3	17.4	11.1	7.5	4.9	5.4	4.2	30.8	6.5	6.7	9.1	2.1	4.7	2.2	8.1	8.2	6.4	6.7	19.4	2.7	9.4	1.3	6	3.5	10	17.9	5.4	8.6	2.8	2.7	1.8	3.2	13.1	7.3	3.4	7.5	7	4.6	8.1	1.7	11.3	3.6	12.2	7.1	2.6	7.2	null	5.5	4.6	5.3	5.3
2023 Q1	3-month period	Hypertension	Age-adjusted	Deaths per 100,000	10.8	10	11.6	null	null	null	null	null	null	null	null	null	null	12	14.7	13.6	11.3	16.4	7.2	7.8	9.4	7.3	11	11.4	6.9	13.1	9.7	8.9	10.1	17.9	9.4	8.7	7.6	9.6	7.9	9.4	12.5	5.8	19.8	7.3	9.7	10.7	14.2	9.4	8.9	4.8	13.7	11.1	9.9	9.5	12.4	8.3	16.2	10.7	5.5	13.2	8.8	5.1	9.2	10.5	10.5	9.2	10.9	7.2
2023 Q1	3-month period	Influenza and pneumonia	Age-adjusted	Deaths per 100,000	13.1	11.5	15.4	null	null	null	null	null	null	null	null	null	null	11.1	17.1	17.7	11.7	14	7.1	12.6	7	8.3	10.3	13.1	15.2	13.7	10.1	14.7	11.8	14.4	16.6	11.6	13.1	10.7	18.6	14.8	8.2	14.6	19.9	9	12.9	15.3	13.6	11.6	10	19.7	17.5	18.1	14.5	16	8.1	13	10.9	10.9	12.4	17	12.2	11.8	10.2	14.2	9.7	11.7	20	15.7
2023 Q1	3-month period	Kidney disease	Age-adjusted	Deaths per 100,000	13.9	11.8	16.6	null	null	null	null	null	null	null	null	null	null	9.3	21.1	21.6	9.9	11.9	10.2	14.3	10.3	10.4	10.7	18.6	14.4	11.3	4.8	17.6	17.5	15.3	22.3	19.2	15.3	10.6	9.8	14.9	6.7	22.8	20.8	8.2	16.9	10.3	10.3	11	14.5	10.9	8	10.2	16.5	11.9	7.5	17.6	6.5	14	11.1	14.9	16.6	12.3	15.7	5.7	6.1	10.1	24.4	22.5
2023 Q1	3-month period	Parkinson disease	Age-adjusted	Deaths per 100,000	9.9	6.5	14.8	null	null	null	null	null	null	null	null	null	null	14	12.1	10.4	8.4	9.8	10.8	9.8	7	11.9	9.4	10	7.9	10	10.7	10.7	11.3	12.6	10.3	11.4	9.8	8.7	10.9	9.9	10.1	10.8	11.4	12.1	10.8	9.4	12.2	10.4	8.3	7.8	6.6	6.6	9.9	11	12	9.2	6.3	10.6	8.3	11	11.7	12.9	10.9	9.1	10.2	11.2	10.8	6.8
2023 Q1	3-month period	Pneumonitis due to solids and liquids	Age-adjusted	Deaths per 100,000	5.1	3.7	7	null	null	null	null	null	null	null	null	null	null	null	4.8	3.8	3	4.7	3.9	1.3	8.4	6.8	4	5.5	6.6	4.9	5.2	6.4	7.2	6.9	5.2	4.5	7.7	5.8	null	3.5	3.8	6.8	5.3	6.2	4.3	8.3	4.9	8.3	6.4	1.9	3.1	3.2	6.3	4.8	2.8	6.6	6.7	6.4	6.7	6.9	6.1	4.9	4.9	3.6	7.6	5.1	2.1	4.1
2023 Q1	3-month period	Stroke	Age-adjusted	Deaths per 100,000	40.4	39.4	40.8	null	null	null	null	null	null	null	null	null	null	36.4	49.7	50.2	34.9	41.2	35.6	32	34.3	63.1	46.3	43.8	44.2	33.4	37	46.2	42.2	37.7	42.7	47	26.9	42.3	34.1	45.1	31.2	41.1	53	28.6	48.8	28.7	35.9	35.8	29.5	40.1	39.9	25.1	48.1	41	45.7	37.8	29.5	44.7	36.3	44.4	43	30.3	44.1	25.5	36.5	36.4	38.1	31.3
2023 Q1	3-month period	Suicide	Age-adjusted	Deaths per 100,000	14.1	5.9	22.6	null	null	null	null	null	null	null	null	null	null	26.7	16.6	20.2	18.2	10.2	18.5	8.9	6.9	15.4	15	15.7	15.2	15.8	23.4	11.5	16.4	19.3	17.3	16.1	8.8	9	18.9	14.7	12.1	18.4	16.2	25.6	13.8	16.4	14.1	15.6	7.4	22.1	20.6	8.2	14.4	21.7	19.4	13.8	9.5	17.2	22.2	16.9	14.1	19.2	13.7	20.6	16.2	15	20.2	27.4
2023 Q1	3-month period	Unintentional injuries	Age-adjusted	Deaths per 100,000	61.9	39	85.8	null	null	null	null	null	null	null	null	null	null	88.5	71.7	58.6	70.8	51.2	64.7	56.2	88.8	88.7	66.9	59.2	37.3	47.9	59.9	53.9	64.7	59.7	88.1	84.4	57.2	50.7	78.3	55.2	55.4	71.1	80.8	52.2	77.5	45.3	42.1	67.9	45.2	90.2	64.7	49.2	76.5	82.3	72.1	67.7	74.3	87.2	49.5	96	47.4	48.7	57.2	73.5	71	73.8	116.7	53.6
2023 Q2	12 months ending with quarter	All causes	Age-adjusted	Deaths per 100,000	774.6	653.9	912	null	null	null	null	null	null	null	null	null	null	813.1	962.4	967.6	745.8	671.4	718.2	678	742.2	806.5	694.5	840	604.3	786.2	756.8	756.9	891.6	846.2	1,002	942.9	684.3	723.3	831.2	830.1	699.7	884.3	1,019.4	781.8	853.8	731.1	778.8	744.1	657.4	853	797.6	645.3	885.1	974.2	804.7	792.7	707.9	890.9	775.9	977	782.6	737.6	771.4	757	754.4	780.1	1,057.2	795.1
2023 Q2	12 months ending with quarter	Alzheimer disease	Age-adjusted	Deaths per 100,000	28.8	32.9	22.5	null	null	null	null	null	null	null	null	null	null	34.3	40.2	39	28.2	37.2	30.9	20.6	8.2	28.2	16.8	39.8	23	29.5	37.8	25.5	27.9	25.9	27.8	39	18.5	16	25.9	32.8	31.6	32.2	49.3	23	33.8	31.9	29.6	25	18.7	26.1	24.7	11.8	33.1	33.8	38.4	21.2	32.6	36.9	33.6	34.4	38.6	39.7	23.9	34.7	41.3	32.1	26.9	30.7
2023 Q2	12 months ending with quarter	COVID-19	Age-adjusted	Deaths per 100,000	18.1	15.1	22.3	null	null	null	null	null	null	null	null	null	null	13.9	21.2	20.9	16	16.5	13.9	17.3	14.2	15.8	15.7	18.3	8.9	19.1	14.4	15.8	20.2	20.7	29.7	17.5	16.9	16.4	18.4	19.2	16.4	20.6	23.9	16.3	19.4	16.2	17.7	17.4	15.7	24.2	18.6	17.9	22.3	25	16.1	19	12	20.5	18.4	25.8	17.9	13.9	18.5	16.7	15.6	16.2	29.9	18
2023 Q2	12 months ending with quarter	Cancer	Age-adjusted	Deaths per 100,000	142.8	125	166.7	null	null	null	null	null	null	null	null	null	null	141.6	157	168.9	130.2	129.9	124.2	128.8	132.5	159.4	135.7	147.1	121.7	146.7	138	146.3	164.2	152.5	181.3	163.6	133.8	138.1	153.7	153.4	139.1	161.5	173.2	143.6	151	130.9	150.9	143.2	126.3	128.6	139.5	122.2	157.3	167	146	149.2	138.8	155.4	147.6	165.6	141.1	118.1	145.4	149	142.6	147.2	174.2	132.2
2023 Q2	12 months ending with quarter	Chronic liver disease and cirrhosis	Age-adjusted	Deaths per 100,000	13.5	9.8	17.5	null	null	null	null	null	null	null	null	null	null	23	15.6	16.6	17.2	14.9	18.1	11.7	8.9	11.7	12.3	12.4	7.4	13	14.7	11	13.7	14.5	16.3	11.9	10.6	8.8	14.9	13.2	12.8	13.2	16.6	20.5	13.5	19.9	13.7	13.2	8.5	33.1	15.6	8	13.6	19.4	16.6	10.6	14.5	15.5	29.6	16	16.1	11.1	10.9	10.9	14.5	12.6	17.6	23.4
2023 Q2	12 months ending with quarter	Chronic lower respiratory diseases	Age-adjusted	Deaths per 100,000	34.7	33.2	36.9	null	null	null	null	null	null	null	null	null	null	36	47.1	60.3	35.6	26.7	38.7	24.6	18.6	29.2	30.9	40.1	16.5	38.9	40.9	31.7	53.8	44.2	58.2	39.8	25.7	25	40.4	39	29.1	45.8	57.2	42.9	39.6	30	41.7	35.6	21.9	37.1	41.5	23.3	42.3	62.4	36	31.9	27.4	39.7	35.7	48.4	33.9	30.4	31.2	30.3	31.1	32.4	60.9	49.1
2023 Q2	12 months ending with quarter	Diabetes	Age-adjusted	Deaths per 100,000	23.3	18.3	29.3	null	null	null	null	null	null	null	null	null	null	19.8	22.8	33.8	24	25	18.1	14.8	19.4	24.3	21.6	21.1	14.7	23	19.6	20.2	28.1	26.2	29.5	29.3	16.1	23.2	26.7	24.8	20.7	24	32.6	23.4	27.1	25.1	23.1	20.3	15.8	30.8	25.4	17.6	27	31.7	25.2	21	18.1	24.6	28	30.5	24.8	24.4	24.9	19.6	22.3	19.3	39.1	23
2023 Q2	12 months ending with quarter	Drug overdose	Age-adjusted	Deaths per 100,000	32.9	19.4	46.5	null	null	null	null	null	null	null	null	null	null	40.4	33.6	19.4	37.1	28.1	30.4	39.1	64.2	53.8	33.5	25.1	21	14.9	21.4	29.4	38.1	25.9	52.9	52	36.6	39.9	52.8	31.1	25.3	36.6	25.4	18.2	41.7	19.9	10	35.2	30.4	49.4	34.2	32.4	45.9	33.2	35.7	40.9	37.2	45.4	12.5	56.6	18.7	21.2	30.1	46.5	40.1	30.9	82.5	24.1
2023 Q2	12 months ending with quarter	Falls, ages 65 and over	Age-adjusted	Deaths per 100,000	79	69.6	91.7	null	null	null	null	null	null	null	null	null	null	79.4	34.7	59.3	86.3	44.6	129.6	67.4	67.3	49	84.3	56.2	52.8	120.6	123	60.8	61.6	97	64	55	91.9	81.9	135	85	148.2	78.2	74.2	92.8	107.3	66.1	61.3	107.1	37.6	69.2	84.6	51.9	95.4	148.5	129.9	88.5	118.3	83.9	115.4	91.7	62.5	115.6	77.8	147.7	103.2	186.5	103.1	89.6
2023 Q2	12 months ending with quarter	Firearm-related injury	Age-adjusted	Deaths per 100,000	14	4.1	24.2	null	null	null	null	null	null	null	null	null	null	22.5	26.2	22.4	18.9	8.3	17.3	6.3	24.5	12.2	13.8	19.3	4	11.9	16.9	14.4	18.1	15.9	18.2	28.1	3.7	12.9	11.1	14.4	8.8	23.6	30	23.7	16.5	15.9	11.1	10.4	5	27.2	18.5	4.9	15.2	19.9	14.3	14.1	3.6	20.6	14.5	21.1	14.7	15.2	14.6	11.4	12.9	13.6	17	22
2023 Q2	12 months ending with quarter	Heart disease	Age-adjusted	Deaths per 100,000	166.9	131.1	209.8	null	null	null	null	null	null	null	null	null	null	147	233.5	222.6	150.4	144.3	128.7	134.1	169.1	162.4	140.5	182.7	126.3	181.1	154.4	165.9	188.5	176.1	203.7	221.3	131.1	153.8	167.8	207.7	124.8	195.7	241.8	166.8	165.4	163.1	161.4	151	151	160.3	189.1	158.4	190.6	257.8	147.6	171.4	155.4	180.1	154	215.1	171.6	161.9	160.7	159	142.6	169.8	210.9	154.7
2023 Q2	12 months ending with quarter	HIV disease	Age-adjusted	Deaths per 100,000	1.3	0.6	2.1	null	null	null	null	null	null	null	null	null	null	null	1.7	1.1	1.2	1.3	0.5	0.9	6.5	null	2.5	2.6	null	null	null	0.9	0.9	0.8	1.1	2.6	0.7	2.1	null	1	0.5	0.8	2.5	null	1.4	null	null	null	1.3	1	1.4	1.6	1	1.6	1	0.9	null	2	null	1.6	1.7	null	1	null	0.6	0.4	null	null
2023 Q2	12 months ending with quarter	Homicide	Age-adjusted	Deaths per 100,000	7.5	2.9	12	null	null	null	null	null	null	null	null	null	null	9.7	15.9	11.8	8.4	5.5	6.7	4.6	27.3	6.4	7	10.8	2.4	3.6	2.8	10.8	8.6	5.6	7.9	19.5	2.7	10.9	2.2	7.7	3.6	12.3	20.3	5	8.7	3.8	3.8	2	3.7	15	8.1	4.2	8.3	7.9	5	8.4	1.8	11.5	6.9	11.3	7.1	2.4	7.4	null	5.4	5.3	5.9	4.6
2023 Q2	12 months ending with quarter	Hypertension	Age-adjusted	Deaths per 100,000	10.3	9.5	11	null	null	null	null	null	null	null	null	null	null	10.2	13.2	13.2	11	14.9	6.2	7.2	11	7.1	9.8	11.4	7.8	12.8	7.2	9	9.8	15.8	10.1	8	7.9	9.5	7.7	9.4	12.1	6.6	18.4	7.1	9.3	9.1	16.7	6.7	8	5.9	13.5	10.8	10	8.7	12.3	7.4	15.1	10.4	8.2	13.2	8.4	5.8	9.6	8.2	10.5	8.8	11	6.6
2023 Q2	12 months ending with quarter	Influenza and pneumonia	Age-adjusted	Deaths per 100,000	11.9	10.3	13.9	null	null	null	null	null	null	null	null	null	null	10.1	15.3	17.5	10.3	12.5	6.4	12.1	7.9	9.7	8.7	11.6	13.9	12.1	9.3	13.6	11.7	13.8	16.3	10.7	10.8	9.1	14.8	11.8	7.4	14.1	21.5	7.6	12.4	11.5	11.8	8.9	9.9	15.5	16.5	15.9	13.1	14.2	7.2	11.5	7.8	10.2	11.6	16	10.7	9.3	10.2	9.9	10	9.3	20.8	11.9
2023 Q2	12 months ending with quarter	Kidney disease	Age-adjusted	Deaths per 100,000	13.5	11.5	16.2	null	null	null	null	null	null	null	null	null	null	12.9	20.5	20.2	8.6	11	9	13.4	8.6	12.9	10.6	19.3	13.7	11.4	6.7	17.8	18	15.7	21.9	19.3	14.7	9.8	11.3	15.1	7.7	21.1	21.1	9.4	15.3	12	10.8	10.9	14.6	12.2	7.3	10	15.6	11	8	16.4	7.9	14	8.9	14.7	15.7	13.8	15.3	5.7	6.4	10.7	23.4	12.2
2023 Q2	12 months ending with quarter	Parkinson disease	Age-adjusted	Deaths per 100,000	9.6	6.4	14.2	null	null	null	null	null	null	null	null	null	null	12.2	11.4	9.8	9.2	9.4	10.4	8.7	5.7	9.9	8.7	9.9	8.2	10.6	10.4	9.8	11.1	11.9	10.1	9.7	8.5	8.2	10.4	10	10.6	10.4	11.2	10	10.1	8.7	12	11	7.8	8.7	7.3	6.5	10.2	10.6	10.8	9.6	8.7	10.3	8.2	11.8	11.2	11.7	10.1	10.5	10.2	10.3	10.4	8.2
2023 Q2	12 months ending with quarter	Pneumonitis due to solids and liquids	Age-adjusted	Deaths per 100,000	4.8	3.5	6.6	null	null	null	null	null	null	null	null	null	null	3.9	4.6	3.8	2.5	4	4.3	1.4	7.8	5.4	3.9	5.2	5.3	5.3	3.9	6	7	5.3	5	3.9	7.5	5.7	null	3.6	3.3	6.1	5.4	5.4	4.5	7.1	5.5	6.1	5.9	2.1	3.6	3.2	6.2	5	2.7	6.2	7.4	6	5	6.3	5.9	4.2	4.5	3.1	7	5.3	2.2	5.1
2023 Q2	12 months ending with quarter	Stroke	Age-adjusted	Deaths per 100,000	39.6	38.8	39.8	null	null	null	null	null	null	null	null	null	null	33	50.5	46.6	33.6	39.7	34.9	30	36.6	61.7	46	43.9	40	32.3	37.2	43.6	41.6	36.2	42.5	47.1	26.1	42.4	31.2	44.9	31.1	40.7	51.8	25.8	49.2	30.9	35.8	31.6	29.7	37.9	37.8	24.3	47.5	38.8	46.1	36.7	29	44.5	34.5	45.1	41.7	32.5	42.2	25.8	36.2	35.9	41.8	28.1
2023 Q2	12 months ending with quarter	Suicide	Age-adjusted	Deaths per 100,000	14.2	6	22.8	null	null	null	null	null	null	null	null	null	null	29.2	16.5	19	19.8	10.2	21.3	9.7	6	13.5	14.1	14.5	16.2	17.8	22.6	12.2	16.5	19.8	17.9	15.4	8.5	8.9	17.4	14.7	13.9	18.1	14.6	29.5	14.4	21.5	15.2	16.2	7.3	24.4	20.6	8.3	14.8	21.8	19.3	14.3	10.3	15.7	22.2	16.3	14.3	22.7	13.5	17.4	16	15	18.6	27
2023 Q2	12 months ending with quarter	Unintentional injuries	Age-adjusted	Deaths per 100,000	64.4	39.6	90.1	null	null	null	null	null	null	null	null	null	null	88.4	70.3	63.8	76	51.9	70	62.2	88.7	83.1	67.8	58.7	41.7	50.7	61.1	55	68.3	62.4	92.9	89.4	60.3	52.2	89.3	59.6	61.8	74.8	78.1	62.7	80.4	50.6	43.8	66.4	48.7	94.8	67.7	51.4	80.5	84.2	74.3	70	67.9	89.6	58	99.4	50.8	51.1	58.5	83.7	72.5	74.4	121.9	65.3
2023 Q2	3-month period	All causes	Age-adjusted	Deaths per 100,000	727.3	611.2	858.9	null	null	null	null	null	null	null	null	null	null	759.1	912.4	906.2	705.8	623.9	692.5	629.5	668.9	754.9	660.1	784.9	570.8	740.9	727.6	712.4	837.3	791.3	929.5	887.9	638.2	667.5	777.7	784.1	658.3	826.9	948	735.9	803	700.1	745.7	692.5	612.6	826	760.4	596.2	832.7	911.5	752.7	745.9	686.1	825.7	740.6	917.2	740.5	701.1	717.5	718.3	708.9	740.9	958.6	768.2
2023 Q2	3-month period	Alzheimer disease	Age-adjusted	Deaths per 100,000	26.1	29.9	20.3	null	null	null	null	null	null	null	null	null	null	24.2	37	34.1	25.8	32.9	29.2	18.3	6.5	24.1	15.3	36.5	24	26.7	32.8	22.3	25.1	20.6	26.8	35.4	16.8	13.8	26.5	30.4	28.6	29.7	47.1	19.2	30.8	28.3	27.8	22.3	17.6	22.2	23.7	10.4	29.3	31.2	35.2	19.4	32.7	33.9	27.2	30.6	35.9	36.5	19.4	32.2	37.1	30	24	25.5
2023 Q2	3-month period	COVID-19	Age-adjusted	Deaths per 100,000	6.6	5.5	8.1	null	null	null	null	null	null	null	null	null	null	4.3	7.2	7.1	8.1	6.6	6.2	3.3	3.8	4.8	6.6	5.4	6.1	7.4	3.5	5.9	6.8	6.3	8.7	5.3	5.2	4.4	8.6	8	8.7	8.1	8.6	8.8	6	7.5	8.7	7.5	4.3	12.6	7.7	5	8.6	6.4	8.1	6	4.4	6.1	9.9	8.7	6.1	5.6	5.6	9.5	7.3	7.3	7.4	6.6
2023 Q2	3-month period	Cancer	Age-adjusted	Deaths per 100,000	139.8	122.1	163.3	null	null	null	null	null	null	null	null	null	null	135.3	152.5	163.8	127.3	125.9	124.8	122.6	115.9	158.4	133.7	145.6	113.9	146	143.7	144.3	161.2	147.9	180.6	157.5	128.9	136.4	156.4	150.2	133.1	156.2	164.4	132.4	148.7	130.8	153.7	145.1	123.7	132.9	135.3	116.9	153.6	162	143	147.4	138.8	148.7	153.5	161.4	139.2	113.1	144.4	149.7	141.5	143.2	165.8	125.8
2023 Q2	3-month period	Chronic liver disease and cirrhosis	Age-adjusted	Deaths per 100,000	12.7	9.3	16.3	null	null	null	null	null	null	null	null	null	null	22.8	16.2	17.8	17.7	13.7	17.9	10.5	7.1	12.2	11.9	11.5	6.4	11.6	15.1	9.2	12.5	14.6	16.6	11.3	9.8	8.4	15.7	12.9	11.6	11.3	14.4	21.8	12.9	22.9	15.2	14	8.2	29.6	13.2	7.1	12.9	17.1	15.2	10	14.8	13.9	29.6	15	15.9	10.9	9.9	11.2	13.6	11.6	14.9	18.2
2023 Q2	3-month period	Chronic lower respiratory diseases	Age-adjusted	Deaths per 100,000	32.9	31.4	34.9	null	null	null	null	null	null	null	null	null	null	34.9	43.2	54.5	34.2	25.1	34.5	24.5	20.3	24.5	29.6	37.6	16.2	38.7	38.3	29.8	52.4	40.6	53.6	37.9	24.7	23.4	40.1	36.8	26.7	44.7	52.3	40	36.2	27.7	42.8	34	20.8	34.9	41.1	22.3	39.4	59.6	37.1	31.1	23.7	35.7	36.2	48.5	31.8	28.1	30.5	28.2	29	30.8	53	51.6
2023 Q2	3-month period	Diabetes	Age-adjusted	Deaths per 100,000	21.6	16.9	27.1	null	null	null	null	null	null	null	null	null	null	18.3	20.8	34.4	23.4	23.4	16.9	12.1	22.4	21.5	19.9	20.1	13.8	20.6	18.5	16.8	25.7	25	26.3	28.3	16.5	21.1	24.6	23	18.9	22.1	28.9	26.6	23.8	27.4	24.8	16.3	15.1	27.1	23.9	15.2	25.7	28.7	24.3	20.3	19.4	22.5	21.2	28	23.2	23.7	21.7	17.1	20.7	19	32.7	18.8
2023 Q2	3-month period	Drug overdose	Age-adjusted	Deaths per 100,000	33.1	19.4	46.8	null	null	null	null	null	null	null	null	null	null	50.7	35.1	19.5	33.9	29.1	32.6	37	58.6	54.8	33	25.5	27.7	17.4	21.2	29.1	34	23.6	51.5	53.5	35.4	40.7	51.1	29.5	26	34	24.6	17.8	42.6	20	8.6	32.4	31.4	54.3	35.4	33.3	44.9	33.3	39.4	40	39.5	45.1	12.2	54.3	18.8	22.5	31	41.1	44	33.4	84.9	23.9
2023 Q2	3-month period	Falls, ages 65 and over	Age-adjusted	Deaths per 100,000	74.4	65.6	86.2	null	null	null	null	null	null	null	null	null	null	62	31.3	64.4	90.4	41.6	109.4	67.8	52.1	36	78.9	50.4	52.4	110.2	122.3	57.6	59.8	89.6	57.5	53.8	89.6	77.2	112.6	89.5	132.3	73.1	64.4	87.8	106.2	57.5	58.7	110.8	42.2	71.2	85.2	47.7	97.2	139.1	116.8	76.7	110.3	83.5	105.7	82.8	57.9	102.4	78.7	134.3	95.5	165.4	82	77
2023 Q2	3-month period	Firearm-related injury	Age-adjusted	Deaths per 100,000	14	4	24.2	null	null	null	null	null	null	null	null	null	null	24.4	25.7	23.3	18.3	7.7	17.4	5.7	30.4	10	13.1	19.4	4.2	10.2	16.8	14.8	19.2	16.2	18.7	31.1	3.5	12.8	9.7	15.2	8.8	24.3	32	23.5	16.9	16.2	12	8.6	5.1	28.3	17.9	5.1	14.7	20.8	13.7	13.6	5.3	18.7	10.5	20.7	15.3	16	14.7	9.8	13	12.6	16.2	28.7
2023 Q2	3-month period	Heart disease	Age-adjusted	Deaths per 100,000	157.7	123.5	198.8	null	null	null	null	null	null	null	null	null	null	136.6	219.6	203.6	142.5	135.4	123.8	130.1	153.9	160.2	134.5	167.1	117.9	169.9	146.4	156	182.4	170.4	191.2	209.4	122.2	141.1	156.5	195.6	116.2	184.4	226	163.1	155.7	163.6	154.6	141.4	139.5	155.9	181.2	148.7	180.4	244.7	134.1	161.7	151.4	170.9	147.6	205.8	164.6	161.2	154.9	143.2	133.9	164	201.6	168.6
2023 Q2	3-month period	HIV disease	Age-adjusted	Deaths per 100,000	1.2	0.6	1.9	null	null	null	null	null	null	null	null	null	null	null	1.4	1.7	1	1.1	0.4	0.6	4.3	2.4	2.2	2.5	null	null	null	0.9	0.9	0.9	0.9	1.9	0.6	2.1	null	0.5	0.6	1.1	3	null	1.2	null	null	null	1.5	null	1.5	1.3	1	1.8	0.8	0.8	null	1.5	null	1.6	1.5	null	0.8	null	0.6	null	null	null
2023 Q2	3-month period	Homicide	Age-adjusted	Deaths per 100,000	7.4	2.7	12	null	null	null	null	null	null	null	null	null	null	10.1	15.2	12.7	7.7	5.1	5.6	5.3	32.3	5.3	6.5	10.8	1.9	3.5	4.2	11.6	7.7	6.3	9.1	23	2.4	11.6	2.5	7.3	3.8	11.7	22.4	4.2	8.1	3.2	2.5	2	3.6	16.7	8.1	4.4	8	8.3	4.3	8	2.9	10.1	7.3	11	7.2	2.3	7.1	null	5.5	5.1	4.8	3.2
2023 Q2	3-month period	Hypertension	Age-adjusted	Deaths per 100,000	9.7	9	10.4	null	null	null	null	null	null	null	null	null	null	9.8	13.3	13.1	10.2	13.8	6.2	6.4	11	6.7	9.5	10.4	5.6	12.5	5.9	8.5	9.4	13.9	8.8	8.3	7.3	9.1	7.6	8.9	11.4	6.3	18.9	6.6	8.1	6.9	16.7	6.1	7	7.6	14	10.2	9.2	7.8	12.4	7.2	14.4	9.9	8.4	13.6	7.9	5	8.7	8.9	10	7.7	10.7	3.7
2023 Q2	3-month period	Influenza and pneumonia	Age-adjusted	Deaths per 100,000	9.8	8.3	11.6	null	null	null	null	null	null	null	null	null	null	6.6	12.1	14.6	9.9	10.7	4.5	11.6	8.7	7.6	7.7	9.4	14	9.1	7.5	10.1	10.4	11.6	11.4	8.8	9	7	9.9	9.6	5.4	12.7	18	8.8	10.2	8.3	10.1	8.2	8.7	12.6	14	13.2	10	12.7	4	9.6	5.2	8.2	9.5	13.2	8.6	6.7	8.5	5.8	7.6	6.8	19.9	6.3
2023 Q2	3-month period	Kidney disease	Age-adjusted	Deaths per 100,000	12.8	10.9	15.3	null	null	null	null	null	null	null	null	null	null	10.9	20.5	19	8	10.3	8.4	11.1	7.1	11.4	9.8	19.1	13.7	12.6	7.2	18	17.2	15.2	22.3	19.9	13.5	9.2	12.6	14.5	7.3	19.9	17.8	7.2	13.6	9.3	10.4	10.9	14.5	10.4	6.7	9.6	14.2	10	7.3	15.5	8.4	12.6	9.6	14.4	14.7	12.8	14.3	8.4	6.2	11.1	17	7.4
2023 Q2	3-month period	Parkinson disease	Age-adjusted	Deaths per 100,000	9	5.9	13.3	null	null	null	null	null	null	null	null	null	null	10.1	11.3	9.5	9	8.4	10	7.5	6.9	8.6	8.6	9.5	6.8	9.8	10.1	9.7	9.6	11.5	9.8	8.3	8.2	7.6	8.7	9	10.3	9.2	11.4	6.7	8.8	8.8	12.6	10.1	6.9	9.5	9.4	5.9	9.5	10.4	8.9	9.4	12.4	9.7	7.9	11.6	10.4	10	8.8	10.7	10	9.2	10.2	6.3
2023 Q2	3-month period	Pneumonitis due to solids and liquids	Age-adjusted	Deaths per 100,000	4.5	3.4	6.2	null	null	null	null	null	null	null	null	null	null	3.7	3.5	3.6	2.5	3.6	4.2	0.9	8.1	3.9	3.6	4.5	6.1	5.1	3.3	6.2	6.6	4.6	4.9	3.5	7.6	5.7	null	3.5	2.2	5.9	5.4	6.2	4.1	7	4.9	5.6	5.8	2.1	4.3	3.2	6.4	3.9	2.7	6.2	7.6	5.8	4.2	6	5.7	3.6	4.4	3.5	5.8	4.8	1.9	5
2023 Q2	3-month period	Stroke	Age-adjusted	Deaths per 100,000	37.9	37.1	38	null	null	null	null	null	null	null	null	null	null	22.8	48.2	44.7	30.3	38.4	37.3	29.1	36.7	67.8	46.2	41.8	37.2	31.2	37.5	41.6	39.8	36.5	40.7	41.2	24.2	39.6	27.8	44.7	31.9	38.2	48.1	24	46	23.7	31.7	25.9	28.6	37.4	34.7	23.6	46.1	37.4	40.3	34.5	27.1	41	32.8	42	40.1	28	37.8	25.6	32	34.7	40.8	24.8
2023 Q2	3-month period	Suicide	Age-adjusted	Deaths per 100,000	14.3	6	23	null	null	null	null	null	null	null	null	null	null	32.4	17.3	21.2	19.3	9.9	22.3	9.5	5.2	15.1	14	14.9	14.4	15.3	23.1	12.9	17.2	19.1	17	15.6	9.2	8.7	15	15.4	15.2	18.1	14.9	29	14.9	24.3	16.7	14	7	24.8	19.7	8.6	14.9	21.5	20.6	13.9	8.6	14.4	22.6	16.4	14.4	25.1	12.9	16.1	16.3	15.5	16.7	36.5
2023 Q2	3-month period	Unintentional injuries	Age-adjusted	Deaths per 100,000	63.8	38.6	89.8	null	null	null	null	null	null	null	null	null	null	92	71.7	61.8	71.7	51.6	69.1	59	78.5	82.6	66.9	57.5	47.3	52.3	57.7	53.4	64.1	58.6	90.5	90.8	58	53.4	80	60	60.5	72.6	74.2	60.3	81.7	48.9	40.7	62	50.3	98.3	70.7	51.5	80.4	83.6	76.3	67.7	65.6	88.9	51	97.9	50.8	48.8	58.9	80	75.2	74.5	123.8	66.1
2023 Q3	12 months ending with quarter	All causes	Age-adjusted	Deaths per 100,000	763.4	643.8	899.2	null	null	null	null	null	null	null	null	null	null	797.6	952.4	958.6	734.5	658.1	713.5	674.8	734.4	791.2	685.2	826.9	600.9	774.7	742.8	744.6	874.8	832.4	986.4	929.3	678.5	716.5	820.9	818.2	691.6	868.9	1,006	758.9	841.1	721.3	776.2	737.7	646.7	847.5	790.1	635.3	871.2	956.9	799.4	781.3	700.2	876.8	767.2	961.8	772.5	731.8	758	760.3	742.2	771.1	1,031.4	783.1
2023 Q3	12 months ending with quarter	Alzheimer disease	Age-adjusted	Deaths per 100,000	28.3	32.2	22.2	null	null	null	null	null	null	null	null	null	null	28.7	38.6	39.3	27.3	36.5	31.5	20	7.7	26.6	16.4	38.4	22.1	30.7	36.7	25.3	27.6	24.3	28	38.2	17.9	16.2	25.9	32.3	32.2	31.9	49.8	21.5	33	32.3	29.5	25.7	18.5	24.7	23.9	11.4	32.5	32.4	37.4	21.1	31.8	36.6	34.5	33.7	37.6	39.3	23.3	32.5	39.4	31.6	25.7	29.7
2023 Q3	12 months ending with quarter	COVID-19	Age-adjusted	Deaths per 100,000	13.9	11.6	17.3	null	null	null	null	null	null	null	null	null	null	10.1	15.2	14.6	13.3	12.7	11.3	14.3	11.3	12.4	11.6	13.2	7.7	14	10.2	11.9	15.7	15.8	21.7	11.8	15.1	13.2	15.6	15.1	13.3	15	16.6	11.9	15	11.1	13.7	15	13	19.1	14.7	15	16.9	17.6	12.8	15.3	10.9	15.7	14.1	19.2	12.7	10.7	13.8	15.6	12.4	12.8	21.5	13.3
2023 Q3	12 months ending with quarter	Cancer	Age-adjusted	Deaths per 100,000	142.4	124.7	165.9	null	null	null	null	null	null	null	null	null	null	138.4	157.4	169.1	128.5	129.1	123.6	129.5	134.6	153.6	134.9	147.2	119.4	146.7	135.4	145.3	163.9	152	181.6	163	133.4	137	154	152.9	138.9	161.1	173.2	139.4	151	136.4	150.9	144.2	125.2	130.5	139.4	121	156.6	167.5	145.4	148.9	135.8	154.9	149.6	164.9	141.2	117.5	145.6	153.4	142.9	148.3	171.9	135.3
2023 Q3	12 months ending with quarter	Chronic liver disease and cirrhosis	Age-adjusted	Deaths per 100,000	13.2	9.6	17.1	null	null	null	null	null	null	null	null	null	null	23.1	15.9	16.8	16.9	14.6	17.8	11.9	8.7	12	12	12.3	7.5	12	14	10.9	13.3	14.1	16.6	11.4	10.4	9.2	14.9	13	12.7	12.7	15.1	19.3	13.2	19	13.5	12.3	8.2	32.5	16	7.8	13.4	19.8	16.3	10.6	15	15.6	28.8	15.6	15.8	11.2	11	11.1	13.5	12.2	17.9	21
2023 Q3	12 months ending with quarter	Chronic lower respiratory diseases	Age-adjusted	Deaths per 100,000	34.4	32.8	36.4	null	null	null	null	null	null	null	null	null	null	36.7	47.2	59.4	34.8	26.5	38.5	24.2	19	28.4	30.8	38.5	16.6	37.9	39.4	31	53	43.3	57.8	39	26.1	25	42	38.6	29	45.7	56.9	41	39	28.7	42.9	36.2	21.7	38	40.7	23.3	41.6	62.1	36	31.4	28.3	38.7	35.6	48.2	33.8	30.7	31.5	32.4	29.8	32.1	59.5	47.8
2023 Q3	12 months ending with quarter	Diabetes	Age-adjusted	Deaths per 100,000	23	17.9	29	null	null	null	null	null	null	null	null	null	null	18.6	22.4	33.4	24.1	24.5	17.3	14.7	20.3	24.1	21.5	21	14.9	23	19.7	19.5	28.5	25.3	29.2	28.5	15.6	23.7	25.6	24.4	20.3	23.7	31.4	23	26.3	25	23.7	19.3	15.6	29.8	24.9	17.4	26.6	30	24.3	20.8	18.4	24.6	26.7	30.4	24.5	23.3	24.6	19.6	21.6	18.9	38.8	24.5
2023 Q3	12 months ending with quarter	Drug overdose	Age-adjusted	Deaths per 100,000	32.6	19	46.1	null	null	null	null	null	null	null	null	null	null	43.9	33.7	19	37.2	28.2	30.8	38.3	62.9	55.2	32.9	24.4	21.9	15.7	20.5	28.8	36.3	24.6	51.5	52.2	35.8	40.1	49.4	30.8	25.1	35.3	25.5	17	38.7	18.3	9.9	35.3	29.8	50.4	36.4	32	44.9	33	40.1	39.4	38.4	43.5	10.9	55.6	18.9	20.9	29.5	45.7	42.5	31	82.8	24.2
2023 Q3	12 months ending with quarter	Falls, ages 65 and over	Age-adjusted	Deaths per 100,000	78.7	69.6	90.8	null	null	null	null	null	null	null	null	null	null	83.6	36.6	60.6	87.5	44.6	125.4	65.2	71.8	55.1	85	56.5	53.5	119.1	123.4	61.6	60.9	91.8	63.3	53.6	91.8	80.2	138	87.1	141.6	74.4	74	95.9	107.2	71.2	62.9	110.5	36.2	73.3	83.6	51.8	96.6	142	127.8	87.3	110.4	86.6	111.5	93.2	62	108.9	79.9	150.8	104.1	184.5	99.6	83.9
2023 Q3	12 months ending with quarter	Firearm-related injury	Age-adjusted	Deaths per 100,000	13.9	4	24	null	null	null	null	null	null	null	null	null	null	22.2	25.6	22	18.5	8.1	17.1	6.2	27.1	12.1	14	19.4	4.6	11.3	18.7	13.9	17.9	16.1	18.8	28.1	3.8	12.8	12.6	14.3	8.7	22.1	30.1	22.3	16.5	14.8	10.4	9.9	4.6	24.9	18.5	4.8	15	20.3	14	13.8	4.6	19.6	12.7	21.5	14.7	14.9	14.7	11.6	13.1	13	16.8	21.6
2023 Q3	12 months ending with quarter	Heart disease	Age-adjusted	Deaths per 100,000	164.8	129.2	207.4	null	null	null	null	null	null	null	null	null	null	136.4	231	223.3	147.8	141.5	128.3	132.4	158.9	163.1	139.5	180.9	125.2	177.8	152.5	163.8	185.9	173.2	198.7	219.1	130.4	152.3	165.3	203.9	122.8	192.9	237.3	166	163.6	161.5	160.8	150.7	148.6	161.3	185.9	155.7	188	253.9	146.7	169.2	152.2	179.8	151	211.9	170.5	161.7	158.5	158.1	139.9	168.4	209	152.8
2023 Q3	12 months ending with quarter	HIV disease	Age-adjusted	Deaths per 100,000	1.3	0.6	2	null	null	null	null	null	null	null	null	null	null	null	1.9	1.2	1.1	1.3	0.5	0.8	6.9	1.7	2.3	2.5	null	null	null	0.9	0.8	0.7	1	2.3	0.6	2.1	null	0.9	0.5	0.8	2.3	null	1.4	null	null	null	1.4	1	1.3	1.6	1	1.5	1.1	0.8	null	1.7	null	1.6	1.8	null	1	null	0.6	0.5	null	null
2023 Q3	12 months ending with quarter	Homicide	Age-adjusted	Deaths per 100,000	7.3	2.8	11.6	null	null	null	null	null	null	null	null	null	null	8.1	15	11.6	7.9	5.1	6.7	4.7	29.6	6.4	7	10.6	2.8	3.3	2.8	10.2	8.1	6.3	7.5	19.1	2.7	10.8	2.2	7.4	3.4	11.3	20.7	4.4	8.6	3.5	3.1	1.7	3.3	14.3	8.1	4	8.2	7.7	4.5	8.1	2.2	11.5	4.7	11.5	7.1	2.4	7.3	3.3	5.2	5.3	5.3	3.8
2023 Q3	12 months ending with quarter	Hypertension	Age-adjusted	Deaths per 100,000	10.2	9.4	11	null	null	null	null	null	null	null	null	null	null	9.8	13.4	12.9	10.9	14.7	6	7.1	12.1	7.2	10	11.1	6.5	13.3	7.5	8.8	9.4	15.1	10	8	7.5	9.1	7.8	9.3	12.4	6.2	18.7	6.2	8.7	9.8	16	6.7	7.8	6.3	13	10.8	9.6	8.6	12.2	7.6	16.4	10	9.1	13.2	8.4	5.8	9.6	9.1	10.1	8.5	10.7	5.6
2023 Q3	12 months ending with quarter	Influenza and pneumonia	Age-adjusted	Deaths per 100,000	11.8	10.2	13.8	null	null	null	null	null	null	null	null	null	null	9.7	15.3	17.9	10.2	12.4	6.3	12.4	8.7	9.4	8.4	11.3	13.9	12	9.1	13.2	11.8	13.9	16.1	10.3	10.6	9.2	14.5	11.5	7.4	14.1	20.4	8.1	12.8	12.8	11.9	9	9.7	15.4	16	15.7	13	14.5	7.3	11.6	7.9	10	12.1	16.4	10.7	9.4	9.9	10	9.8	9.1	20.4	12
2023 Q3	12 months ending with quarter	Kidney disease	Age-adjusted	Deaths per 100,000	13.3	11.3	15.8	null	null	null	null	null	null	null	null	null	null	13.7	20.2	19.7	8.4	10.7	8.7	13.7	7.9	12.4	10.2	18.8	13.5	11.6	6.5	17.9	17.8	15.5	21.9	19.1	14.3	9.7	11.5	15	7.1	21.2	20	9.1	15.6	10.9	10.7	10.9	14.4	11.5	7.3	9.8	15.6	10.7	7.6	16.3	8	13.6	8.8	14.7	15.4	12.9	14.6	5.8	5.7	10.6	21.5	12.7
2023 Q3	12 months ending with quarter	Parkinson disease	Age-adjusted	Deaths per 100,000	9.6	6.4	14.1	null	null	null	null	null	null	null	null	null	null	11.9	11.6	9.6	9.1	9.2	10.6	9	5.6	8.9	8.9	9.9	7	11.1	10.4	9.9	10.9	11.5	10.5	9.7	8.6	8	9.9	10	10.6	10.6	11.1	9.5	10.1	8.1	12.7	10.4	7.6	9.1	7.5	6.2	10.3	11	10.5	9.8	9.5	10.8	8.2	11.7	10.9	12.2	9.7	10.5	10.4	10.4	10.7	7
2023 Q3	12 months ending with quarter	Pneumonitis due to solids and liquids	Age-adjusted	Deaths per 100,000	4.8	3.5	6.6	null	null	null	null	null	null	null	null	null	null	4.8	4.5	3.7	2.5	4.1	4.1	1.3	8	5	3.8	5	5.2	5.2	4	6	6.6	5.8	5.3	4	7.7	5.8	null	3.5	3.4	6	5.8	4.9	4.7	7.1	5.4	6.3	6.1	2.1	3.5	3.1	6.1	4.6	2.9	6.3	7.8	6.2	5.7	6	6	4	4.6	2.9	7	4.9	2.1	4.8
2023 Q3	12 months ending with quarter	Stroke	Age-adjusted	Deaths per 100,000	39.2	38.4	39.5	null	null	null	null	null	null	null	null	null	null	33.1	50.1	47	33	39.4	35	31.2	38.7	62.1	45.6	43.6	41	32	36.1	43.6	41.6	36	41.4	47.1	26.4	42.3	30.6	44.3	31.4	39.8	51.7	27.3	48.3	28.8	35.9	31.4	29.3	38.6	38	24.2	47.3	38.1	44.3	35.6	29.4	43.2	34.1	44	41	31.2	41.5	26.7	35.4	35.6	40.6	27.7
2023 Q3	12 months ending with quarter	Suicide	Age-adjusted	Deaths per 100,000	14.2	5.9	22.9	null	null	null	null	null	null	null	null	null	null	28.7	16.8	19.5	18.8	10.1	21.3	9.1	6.1	13	14.4	15	16.5	16.5	24	12.3	16.5	19.7	18.2	15.4	8.7	8.9	19	15	13.7	17.9	15.1	27.7	14.5	19.9	14.6	15.5	7.3	22.9	21.1	8.3	14.8	22.3	18.7	14.2	11.1	15.3	21.6	16.9	14.1	22.2	13.9	17.5	16.1	15.1	18.4	26.9
2023 Q3	12 months ending with quarter	Unintentional injuries	Age-adjusted	Deaths per 100,000	64	39.2	89.5	null	null	null	null	null	null	null	null	null	null	92.1	70.1	62.3	77.7	51.5	69	60.5	87.6	84.5	67.4	58.2	47.6	51.3	60.6	54.6	66.4	61	91.7	89.9	59.5	54.2	86.1	59.2	60.4	73.7	79.3	59.4	76.8	50.8	42.6	67.4	48	94.9	71.6	50.5	78.8	82.9	77.9	68.3	66.3	86.9	57.9	98	51.2	50.3	57.8	82.2	74.6	74.7	121.5	64.3
2023 Q3	3-month period	All causes	Age-adjusted	Deaths per 100,000	718.9	601.5	851.5	null	null	null	null	null	null	null	null	null	null	747.1	912.1	918.5	695.1	609.7	674.3	635.7	702.9	710.2	670.6	790.8	589.9	722.4	708.2	692.8	821.3	764.1	915.8	889.7	640.5	677	763.6	762.7	647.4	805.3	974.6	711.6	798.6	688.7	738.6	697.8	597.6	797	756	585.6	807.6	902.6	757.3	716.9	635.3	832.9	732.2	913.4	740.7	702.7	713.7	730.9	697.9	716.1	943.3	757.4
2023 Q3	3-month period	Alzheimer disease	Age-adjusted	Deaths per 100,000	25.8	29.2	20.7	null	null	null	null	null	null	null	null	null	null	15.6	34.8	37.1	23.8	33.3	29.7	17.2	7.2	21.1	15.5	36.5	20.4	29.7	36.3	23.1	25.8	19.1	27.2	37.2	14.8	14.6	23.8	29.1	29.6	29.8	49.6	18	30.9	28.6	28.2	26.1	16.7	21	21.1	9.7	29.2	27.9	33	18.2	25.9	35.4	31.7	33.5	34.5	37.4	22.2	27.8	33.9	27.1	20.8	29.8
2023 Q3	3-month period	COVID-19	Age-adjusted	Deaths per 100,000	8	6.6	10	null	null	null	null	null	null	null	null	null	null	13.3	10.7	9.2	5.5	8.2	4.9	6.1	7.8	6.7	11.6	10.2	10.3	5.1	7.1	4.9	8.6	7.1	12.2	9.2	8.5	7.4	6.5	5.8	4.9	6.5	11.2	4.6	9.1	4.9	2.7	5.8	6.5	7	7.8	7	7.3	7.6	8.2	6.7	7.2	10.8	8.4	12.7	8	6	7.2	12.6	8.6	4.6	10	6.9
2023 Q3	3-month period	Cancer	Age-adjusted	Deaths per 100,000	142	124.6	165.2	null	null	null	null	null	null	null	null	null	null	133.5	156.3	168.2	124.7	129.2	122.9	135.1	148.1	140.2	134.4	149.7	113	143.2	132.3	143.9	165.8	146.9	179.8	160.9	134	138.7	154.5	152.9	138.6	158.7	173.2	132.5	149.7	150.1	150.3	141.4	122.3	133.4	139.9	121.2	155.5	173.4	146.7	148.9	131.2	154	153.3	163.8	141.1	120.9	147.8	156.3	142.4	148.2	165.7	149.3
2023 Q3	3-month period	Chronic liver disease and cirrhosis	Age-adjusted	Deaths per 100,000	12.5	9.2	16	null	null	null	null	null	null	null	null	null	null	22.5	16.5	16.3	15.4	13.1	17.3	11.2	6.7	10.3	11.4	11.1	7.5	10.2	13.5	10.9	12	12.3	16.4	9.8	10.4	9.9	14.1	13.2	12.5	12	12.9	18.4	12.8	14	13.6	10	7.4	29	16.9	7.2	12.7	19.5	14.6	9.9	16.4	16.1	21.5	14.4	14.8	9.7	11.6	12.1	12.4	11.4	19.6	18.6
2023 Q3	3-month period	Chronic lower respiratory diseases	Age-adjusted	Deaths per 100,000	30.3	28.7	32.5	null	null	null	null	null	null	null	null	null	null	33.8	42.8	51.1	28.5	22.7	33.1	21.3	18	25.3	29.3	33.3	17	34.4	33.8	26.5	46.5	35.1	51	35.3	24.5	21	39.5	32.7	25.8	39.5	53.2	32.1	35.6	25.2	41.5	34.1	18.3	35.1	34.6	20.3	36.7	53.1	31.8	27.1	25.2	34.1	30.2	42.4	30.4	28.3	28.8	32.1	24.8	28	49.8	42
2023 Q3	3-month period	Diabetes	Age-adjusted	Deaths per 100,000	21	16.1	26.7	null	null	null	null	null	null	null	null	null	null	18	21.6	30.4	21.9	21.7	14.2	13.8	17.6	19.7	21.3	19.7	14.6	22.6	19.5	16.8	28.7	23.7	25.9	26.7	13.8	22	22.8	21.7	19	22	28.7	21.9	24.2	19.5	23	20.1	14.3	25.7	19.9	15.7	23.6	27.1	20.2	18.4	18.6	22.4	23.8	29	22	21.7	23.1	17.9	19.2	15.7	36.4	29
2023 Q3	3-month period	Drug overdose	Age-adjusted	Deaths per 100,000	31.8	18	45.6	null	null	null	null	null	null	null	null	null	null	44.7	34.1	19	45.7	29.4	30.7	37.5	64.4	54.2	33.1	22.5	26.4	16	18.5	25.9	35.8	22.8	46.3	53	34.1	37.7	45.2	28.5	23.2	32.2	25.9	13.9	29.7	14.6	10.5	34.9	28.4	51.4	45.5	30.1	42.4	30.9	46.8	35	34.7	38.3	8.2	52.4	20.5	19.4	27.5	48.6	43.7	30.8	82.4	20.5
2023 Q3	3-month period	Falls, ages 65 and over	Age-adjusted	Deaths per 100,000	75.5	67.1	86.3	null	null	null	null	null	null	null	null	null	null	89.6	34.6	69.2	83.6	41.9	108	52.2	65.9	62	82.3	59	42.4	116.2	119.9	60.8	61.1	82.2	66.1	54.5	87.9	69.4	147.2	85.9	133.9	65.7	74.8	107.9	101.3	75.5	71.1	114.2	30.5	65.5	84.5	48.1	90.8	130	122.6	81.3	98.1	79.2	119.1	99.9	65.3	85.3	74	148.3	102.7	177.6	84.9	91.2
2023 Q3	3-month period	Firearm-related injury	Age-adjusted	Deaths per 100,000	14.3	4.2	24.6	null	null	null	null	null	null	null	null	null	null	23.3	25.1	21.9	18.9	8.5	16.7	6.2	34.1	11.7	14.8	18.4	6.1	9.7	21.4	14.6	17.2	18.1	21.3	25.6	4.2	13.7	15.5	15.1	9.6	19.9	30.1	17.9	18	12.4	10.4	9.7	4.2	23.6	19.7	5.6	15.7	23.1	13.6	14.3	5.5	18.5	12.8	22.1	15.5	14.6	15	12.8	13.9	12.7	15.2	18.4
2023 Q3	3-month period	Heart disease	Age-adjusted	Deaths per 100,000	152.7	119	192.8	null	null	null	null	null	null	null	null	null	null	111.4	215.7	217.8	135.3	126.2	122.2	120.5	128.9	149.5	136.4	172.4	121.1	164.8	142	152.2	170.5	152.2	181.2	208	124.4	143.4	151.4	184.8	112.8	177.3	232.6	162.2	153.1	153.4	154.4	144.4	135.9	152.8	173.3	139.7	171.1	237.3	135	153	129.7	169.6	144.5	198.3	160.8	152.7	148	144.2	128.9	155.6	187.7	143.9
2023 Q3	3-month period	HIV disease	Age-adjusted	Deaths per 100,000	1.2	0.6	1.8	null	null	null	null	null	null	null	null	null	null	null	2.1	1	0.6	1.2	0.4	1.1	7.5	3	2.2	2.4	null	null	null	0.8	0.5	0.6	0.7	1.4	0.7	1.8	null	0.7	0.5	0.6	1.5	null	1.4	null	null	null	1.3	null	0.9	1.4	0.7	1.2	1.4	0.5	null	1.1	null	1.4	1.7	null	0.9	null	0.7	0.8	1.5	null
2023 Q3	3-month period	Homicide	Age-adjusted	Deaths per 100,000	7.4	3	11.7	null	null	null	null	null	null	null	null	null	null	8.4	13.3	10.8	7.6	5.4	6.6	4.9	35.7	6.8	7.1	9.9	5	2.2	1.8	10.3	8.1	8.3	8	16.3	2.8	11.2	2.1	8.1	3.2	10.2	19.4	2.6	8.9	4.2	4	1.8	3.2	15.8	9.1	4.7	9.2	8	3.9	8.1	3.1	12.8	3.5	11.3	7.4	2.1	7.2	4.3	5.5	6.3	5.5	3.7
2023 Q3	3-month period	Hypertension	Age-adjusted	Deaths per 100,000	9.3	8.6	10	null	null	null	null	null	null	null	null	null	null	7.2	12.8	11.2	10.8	12.7	4.9	6.5	15.5	6.3	9.5	10.8	5.1	13.5	7.7	8	8	12	9.1	7.1	6.8	8.2	6.4	8.8	12.1	5	17.1	5.5	7.9	10.9	15	5.1	7.1	6	10.9	10.1	8.4	8.7	10.9	7	16	9	12.4	12.6	8.4	6.2	9.1	8.2	8.3	7.2	9.3	4
2023 Q3	3-month period	Influenza and pneumonia	Age-adjusted	Deaths per 100,000	8.4	7.2	10	null	null	null	null	null	null	null	null	null	null	5.9	11.8	13.8	6.9	8.9	4.4	8.7	7.3	6.9	6.3	8.3	10.4	7.7	3.5	9.4	8.2	9.8	9.9	7.9	7	7.4	6.7	7.2	5	9.9	13.7	6.3	9.7	13.1	7.2	7.4	7.4	8.5	9.9	12.3	9	9.7	3.6	8.4	5.2	7.2	10.2	13.5	8	6.9	7.1	2.6	5.9	5.4	13.1	7.8
2023 Q3	3-month period	Kidney disease	Age-adjusted	Deaths per 100,000	12.2	10.5	14.4	null	null	null	null	null	null	null	null	null	null	17.4	18	19	7	9.3	6.8	13.5	6.2	11.4	9.9	16.6	13.9	11.3	6.8	16.3	16.9	15	20.8	18.1	12.8	8.8	10.2	13.7	6.1	20.6	17.2	10.6	15.7	13.8	10.3	9.7	13	10.6	7.7	8.4	14	9.5	6.9	15.6	7.1	13.1	6.5	13	14.3	12.5	13.1	3.9	4.5	9.7	17.6	12
2023 Q3	3-month period	Parkinson disease	Age-adjusted	Deaths per 100,000	9.3	6.3	13.4	null	null	null	null	null	null	null	null	null	null	7.9	10.7	10	9	8.8	10.8	9.3	4.6	6.6	9	9.7	4.9	11.4	11.2	9	10.1	10	10.7	10.7	8.3	6.7	8.3	9.5	10.4	10.4	10.1	7.2	9.9	5.7	12.8	10.9	7	10.3	7.6	5.6	10.3	11.2	9	9.4	9.1	11.3	7	11.3	10.3	14.7	9.2	11.7	10.1	9.9	10.6	6.9
2023 Q3	3-month period	Pneumonitis due to solids and liquids	Age-adjusted	Deaths per 100,000	4.4	3.2	6	null	null	null	null	null	null	null	null	null	null	5.5	4.2	2.9	2.2	3.5	3.4	1.4	8.2	4.5	3.5	4.2	3.6	4.1	4.1	4.9	5.6	7.1	5.3	3.8	7.7	5.6	null	3.4	3.6	4.8	6.2	3.8	5.2	6	5.6	4.8	5.8	2.2	2.2	2.8	5	4	2.6	5.4	8.8	6.3	6.3	4.3	6	3.5	4.1	2.5	6.5	4.2	1.8	4.7
2023 Q3	3-month period	Stroke	Age-adjusted	Deaths per 100,000	37	36.1	37.4	null	null	null	null	null	null	null	null	null	null	32.8	50.8	47.1	29.4	36.6	33.3	29.7	42.5	58.7	44	43.2	40.2	29.6	32.6	41.7	40.3	33.2	36.5	46	25.5	42.4	29.1	43	30.4	36.9	52.2	29.4	45.4	26.1	31.8	29.5	26.9	37.3	35.1	22.4	44.7	34.9	38.8	31	26.7	40.7	28.4	41.4	38.4	29.7	37.8	26.5	34.4	33.2	37.8	29.2
2023 Q3	3-month period	Suicide	Age-adjusted	Deaths per 100,000	14.8	6.1	23.9	null	null	null	null	null	null	null	null	null	null	25.3	18.2	22.1	19.9	10.8	22	8.6	5.7	10.8	15.4	14.8	18	15.6	25.4	12.8	16.4	22.4	19.3	15	9.5	9	22.1	15.4	14.3	18.8	16.2	26.2	15.2	17	13.9	15.2	7.4	21.7	22.8	8.6	15.3	25.1	17.8	14.9	13.4	14.6	21.5	19	14.9	21.9	15.1	19.3	16.2	15.4	19.6	19.3
2023 Q3	3-month period	Unintentional injuries	Age-adjusted	Deaths per 100,000	64.7	38.4	91.6	null	null	null	null	null	null	null	null	null	null	96.3	69.6	64.4	94.9	53	69.3	59.5	90.2	80.2	67.6	56.1	66.2	53.5	65.6	53.1	70.5	59.1	89.6	93.2	59.4	55.5	87.6	58	60.8	73.8	83	64.6	68	56.1	41.8	70.9	48.4	95.8	90.2	48.9	75.3	83	85.7	64.9	59.6	80	62.6	95.6	56.1	49.6	56	84.7	78.3	76.3	119.6	60.7
2023 Q4	12 months ending with quarter	All causes	Age-adjusted	Deaths per 100,000	750.5	632.9	884.3	null	null	null	null	null	null	null	null	null	null	791.4	939.5	941.2	716.5	645.6	703.5	661.3	716	772.8	674.8	812.5	586.7	767.8	730.7	730.6	856.7	813.5	968.7	920.8	670.6	708.5	808.3	800.6	681.7	849.1	992	754	833.3	711.2	766.3	728.5	635.7	836.6	776.4	622.2	851.7	943.5	782.5	768.5	699.8	861.3	753.5	946.9	761.8	732.4	747.2	740.8	727.1	757.1	1,001.2	771
2023 Q4	12 months ending with quarter	Alzheimer disease	Age-adjusted	Deaths per 100,000	27.7	31.7	21.7	null	null	null	null	null	null	null	null	null	null	27.1	37.4	39.5	26.1	35.3	30.6	18.9	7.6	24.2	16.1	38.9	21.7	30.4	35.6	24.6	27.5	22.8	27.9	37.2	18.1	15.4	25.4	32.1	32	31.8	49.8	22.1	32.4	33.9	29.8	25.7	18.5	22.8	23.1	11.3	32.3	32.3	36.2	21	31.1	35.1	34	33.6	36.8	40.3	22.5	33.2	38	31.2	24.9	28
2023 Q4	12 months ending with quarter	COVID-19	Age-adjusted	Deaths per 100,000	11.9	9.9	14.7	null	null	null	null	null	null	null	null	null	null	8.5	14.2	12.9	9.4	10.6	10	10.8	8.8	11.7	10.1	11.4	7.2	11.9	8.7	10.5	13.8	13.5	19.1	10.8	12.8	12	14.4	12.5	12	13.7	15.5	11.6	13.5	10.6	11.7	12.9	10.9	15.7	11.1	11.3	14.1	15.2	11.6	13	9	13.6	13.2	16.5	11.1	8.9	13	12.8	10.6	10.6	18.9	12.2
2023 Q4	12 months ending with quarter	Cancer	Age-adjusted	Deaths per 100,000	141.8	124.1	165.3	null	null	null	null	null	null	null	null	null	null	141	156.2	166.6	127.2	128.3	124.2	129.1	131.5	151.2	134.8	146	119	148.1	138.8	144.7	161.6	149.3	181.6	161.4	132.9	137.8	154	152	138.7	159.2	172.4	138.3	151.1	138.7	149.4	142.9	124.3	131	139.2	120.6	156.1	168.3	144.7	148.2	140.5	152.1	148.3	165.6	140	122.2	144.8	148.7	142.7	146.8	172.9	137.7
2023 Q4	12 months ending with quarter	Chronic liver disease and cirrhosis	Age-adjusted	Deaths per 100,000	13	9.5	16.8	null	null	null	null	null	null	null	null	null	null	24.8	15.1	16.8	16.5	14.3	18.4	11.6	7.5	11.8	11.7	12	7.5	11.1	14.4	10.9	12.7	14	16.8	10.9	10.4	8.9	14.7	13.2	12.5	12.2	14.4	20.1	13	17.9	13.6	12.1	8	31.9	15.7	7.6	13.1	18.8	16.4	10.2	15.1	15	26.2	15.1	15.9	10.5	11.1	11.2	13.3	12.3	17.1	19.3
2023 Q4	12 months ending with quarter	Chronic lower respiratory diseases	Age-adjusted	Deaths per 100,000	33.4	32	35.4	null	null	null	null	null	null	null	null	null	null	34.9	45.8	57.4	33.4	25.7	36.3	24.1	17.4	28.8	30.4	37.9	16	38.7	37	30.1	51	41.6	57.4	38.4	26	24.2	40.7	37.1	28.2	44.3	55.5	41.2	37.9	28.4	41.9	35.7	20.8	36.3	38.3	22.5	39.8	60.7	34.2	31	27.4	37.6	35.8	48.1	32.8	29.4	31.3	32.1	28.4	31	55.3	47.6

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.